Recombinant Human CCKBR Protein，His

CCKBR, or cholecystokinin B receptor, is a G protein-coupled receptor that plays a critical role in various physiological processes, including digestion, anxiety, and pain modulation. It is predominantly expressed in the brain and gastrointestinal tract. Research into CCKBR has gained significant interest due to its involvement in food intake regulation and its potential implications in obesity and eating disorders. Abnormalities in CCKBR signaling have also been linked to psychiatric conditions, necessitating further exploration of its therapeutic potential. The development of CCKBR recombinant proteins provides a valuable tool for studying the receptor's structure-function relationships and facilitating drug discovery efforts aimed at modulating its activity. These recombinant proteins can be used in multiple assays, including ligand-binding studies and functional assays, to elucidate the receptor's mechanisms and interactions with various ligands. Furthermore, understanding the signaling pathways associated with CCKBR could lead to novel therapeutic strategies for managing obesity, mood disorders, and other related conditions. The ongoing research in this area highlights the importance of CCKBR as a target for pharmacological interventions, making it a prominent focus in both neuropharmacology and metabolic studies.